Follow on Google News News By Tag * Healthcare * Pharmaceutical * Ratings * Health * Insurance * Bill * Regime * Hospital * Construction * Law * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | Recently released market study: Kuwait Pharmaceuticals & Healthcare Report Q4 2010New Healthcare market report from Business Monitor International: "Kuwait Pharmaceuticals & Healthcare Report Q4 2010"
The healthcare development plan centres on the construction of eight public hospitals - with 600 beds each - by 2016 and nine new towers for existing hospitals in order to deal with the heavy pressure the healthcare sector is likely to be placed under. The KWD304mn (US$1.05bn) Jaber-al-ahmed al-Sabah Hospital, which is to be completed by 2013, takes the overall bill for the hospital construction programme to around KWD1.62bn (US$5.59bn). The US$160mn project to build nine towers to be annexed to hospitals - adding 2,000 hospital beds - suggest that the political will is there for the necessary healthcare improvements. Nevertheless, for Kuwait, the potential for growth in healthcare construction is heavily contingent on the political environment, with many previous projects plagued by disputes between the executive and the legislature. The Ministry of Health's plan to implement a new health insurance bill for Kuwaiti citizens has given rise to controversy as the law is questioned due to the previous failure of a similar law for expatriates. The cabinet is planning to produce a draft law on the healthcare insurance bill during parliament's next session, which begins in October 2010. The bill is partly designed to curtail medical tourism on the part of Kuwaiti citizens, most likely by extending insurance to procedures and treatments that are commonly sought abroad and paid for by the state. Consensus had been reached by mid-August 2010 on the creation of a Public Health Authority (PHA), which will regulate health insurance, according to Kuwait Times. Despite a relatively small population, BMI expects steady population growth and the highest life expectancy in the Gulf Cooperation Council (GCC) to drive demand in the sector, with recent developments suggesting that, crucially for Kuwait, the political environment is increasingly favourable for the implementation of the programme. The overall healthcare sector will expand by a local currency compound annual growth rate (CAGR) of 8.47% over 2009-2014 on the back of the healthcare development plan. By 2014, we forecast a growth in spending to KWD1.37bn (US$4.88bn), with public sector expenditure continuing to provide the majority of funds at 74.7%. Kuwait's drugs expenditure stood at around KWD106mn (US$365mn) in 2009. Over the forecast period to 2014, BMI expects the market to grow at a CAGR of just under 6.06.19% to reach KWD143mn (US$510mn). For more information or to purchase this report, go to: - http://www.fastmr.com/ Partial Table of Contents: Executive Summary SWOT Analysis - Kuwait Pharmaceuticals And Healthcare Industry SWOT - Kuwait Political SWOT - Kuwait Economic SWOT - Kuwait Business Environment SWOT Pharmaceutical Business Environment Ratings - Table: Middle East And Africa - Regional Pharmaceutical Business Environment Ratings For Q410 - Rewards - Risks Kuwait - Market Summary - Regulatory Regime - Foreign Direct Investment Regulations - Intellectual Property Regime - IP Shortcomings - Pricing Regime - Reimbursement Regime - Public Procurement of Medicines - Regional Harmonisation - Free Trade Agreements Industry Developments - Epidemiology - Communicable Diseases - Non-Communicable Diseases - Healthcare Sector - Primary Care - Secondary Care - Recent Public Health Developments - Healthcare Insurance - Healthcare Reforms - International Collaboration - Research And Development - Biotechnology Sector - Medical Devices - Table: Diverse Potential For Product Launches: New Products For 2009 Industry Forecast Scenario - Overall Market Forecast - Key Growth Factors - Industry - Macroeconomic Forecast - Table: Kuwait - Economic Activity - Prescription Drug Market Forecast - Patented Drug Market Forecast - Generic Drug Market Forecast - OTC Medicine Market Forecast - Medical Device Market Forecast - Pharmaceutical Trade Forecast - Other Healthcare Data - Key Risks To BMI Forecasts Competitive Landscape - Pharmaceutical Sector - Recent Pharmaceutical Sector Developments Company Profiles - Local Companies - Kuwait-Saudi Pharmaceutical Industries (KSP) - Advanced Technology Company - Bader Sultan & Bros - Safwan Trading And Contracting Company - Multinationals - Novartis - Sanofi-Aventis - Pfizer - GlaxoSmithKline - Merck & Co - Johnson & Johnson Country Snapshot: Kuwait Demographic Data - Section 1: Population - Table: Demographic Indicators, 2005-2030 - Table: Rural/Urban Breakdown, 2005-2030 - Section 2: Education And Healthcare - Table: Education, 2002-2005 - Table: Vital Statistics, 2005-2030 - Section 3: Labour Market And Spending Power - Full Table of Contents is available at: -- http://www.fastmr.com/ About Business Monitor International Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. View more research from Business Monitor International at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number